The Global Health Body Raises Alert Over Critical Scarcity of Weight-Loss Injections
Less than one in 10 individuals that would benefit from GLP-1 drugs such as Wegovy have access to them, caution the global health agency as it publishes its first guidance on the drugs.
Given in excess of 1,000,000,000 people worldwide currently obese, it is urging increased and just access to these injectable treatments.
Per forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.
"Our new guidelines acknowledges that excess weight is a chronic disease that can be treated with holistic and lifelong support," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and supply-chain constraints are major barriers to widespread access to the injections that can help people shift significant body mass, notes the organization.
GLP-1 Therapy Shortage
Even under the current best projected case, the manufacturing of GLP-1 therapies could only cover approximately 100 million people – under 10% of those who need them, according to the health organization.
The guideline urges nations and manufacturers to increase access, through measures including licensing agreements.
Exclusive production rights on the active ingredient – the main component of a leading brand – is due to expire in several nations in 2026.
How Weight-Loss Injections Function
These medications imitate a body's own hormone to slow digestion, suppress the appetite and boost satiety so users eat less.
Patients commonly begin shedding pounds in the initial weeks of starting on the once-weekly jabs.
Evidence suggests people may put most of the weight back on after a year of stopping the medication, because their typical hunger return.
To be carrying excess weight raises your chance for developing health problems, such as type 2 diabetes, cardiovascular issues, stroke, and specific cancers.
Excess weight affects individuals in every country and was responsible for millions of fatalities worldwide in 2024, as per the WHO.
